Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

27/10/2022 Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research-The ConPhyMP-Guidelines 01/06/2022 Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN-SPIDERS 10/03/2022 Heterogeneity in the Identification of Potential Drug-Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations 23/09/2020 STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline 28/11/2019 Guidelines for reporting case studies and series on drug-induced QT interval prolongation and its complications following acute overdose 26/07/2017 Guidance to develop individual dose recommendations for patients on chronic hemodialysis 11/10/2016 Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective 20/04/2016 Developing the Clarity and Openness in Reporting: E3-based (CORE) reference user manual for creation of clinical study reports in the era of clinical trial transparency 11/03/2016 Reporting guidelines for population pharmacokinetic analyses 17/03/2015 Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement

Blog archives

Latest guest blogger